CONTEXT: Recent genome-wide association studies have identified several single-nucleotide polymorphisms (SNPs) that are associated with body mass index (BMI)/obesity. OBJECTIVE: As obesity is an independent risk factor for hypertension, the objective of the study was to investigate the associations of obesity susceptibility loci with blood pressure (BP)/hypertension in a population of Chinese children. DESIGN, SETTING AND PARTICIPANTS: This was a genotype-phenotype association study. Participants included 3077 Chinese children, aged 6-18 years. Based on the Chinese age-and sex-specific BP standards, 619 hypertensive cases and 2458 controls with normal BP were identified. MAIN OUTCOME MEASURES: BP was measured by auscultation using a standard clinical sphygmomanometer. RESULTS: Of the 11 SNPs, only FTO rs9939609 was significantly associated with systolic BP (SBP; P ¼ 0.034) and three SNPs were significantly associated with diastolic BP (DBP; GNPDA2 rs10938397: P ¼ 0.026; FAIM2 rs7138803: P ¼ 0.015; NPC1 rs1805081: P ¼ 0.031) after adjustment for age, sex and hypertension status. In addition, three SNPs were significantly associated with hypertension risk after adjustment for age and sex (FTO rs9939609: odds ratio (OR) ¼ 1.35, 95% confidence interval (CI) 1.12-1.62, P ¼ 0.001; MC4R rs17782313: OR ¼ 1.22, 95% CI 1.06-1.42, P ¼ 0.007; GNPDA2 rs10938397: OR ¼ 1.17, 95% CI 1.02-1.34, P ¼ 0.021). After additional adjustment for BMI, none remained significant. The genetic risk score (GRS), based on three significant SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397), showed a positive association with SBP (P ¼ 5.17 Â 10 À 4 ) and risk of hypertension (OR ¼ 1.22, 95% CI 1.12-1.33, P ¼ 6.07 Â 10 À 6 ). Further adjustment for BMI abolished the positive associations (SBP: P ¼ 0.220; DBP: P ¼ 0.305; hypertension: P ¼ 0.052). Only FTO rs9939609 and GRS were statistically associated with hypertension risk in the age-and sex-adjusted model after correction for multiple testing.
INTRODUCTION
Hypertension is a main risk factor for the morbidity and mortality of cardiovascular diseases worldwide. 1 It is well established that hypertension results from both genetic and environmental factors and their interactions. 2 Obesity is an independent risk factor for hypertension. 3 The rapid increase in the prevalence of obesity has contributed to rising prevalence of hypertension over the past two decades. 4, 5 Thus, intervention programs targeting obesity will be an effective measure to reduce the incidence of hypertension.
Recently, genome-wide association studies (GWASs) have identified many single-nucleotide polymorphisms (SNPs) associated with body mass index (BMI)/obesity in populations of European descent, [6] [7] [8] [9] [10] [11] [12] as well as in East Asian populations. 13, 14 Interestingly, the fat mass and obesity-associated (FTO) locus was initially reported as the type 2 diabetes susceptibility gene by the GWAS. 13 However, the FTO-type 2 diabetes association disappeared after adjustment for BMI, suggesting the effect of FTO locus on type 2 diabetes was completely mediated by BMI. 13 Then, the FTO locus was considered as the first gene for common obesity. Since then, other SNPs in/near the MC4R, GNPDA2, BDNF, FAIM2, NPC1, SEC16B, SH2B1, PCSK1, KCTD15 and BAT2 have emerged. However, few studies have focused on the association of these loci with blood pressure (BP) and hypertension, especially in East Asians. As obesity is strongly associated with hypertension, the two diseases may share the similar genetic architecture. It is unclear whether the recently identified obesity susceptibility loci also associate with hypertension and whether the associations are independently of, or mediated through, BMI. This information may help our understanding of the association between obesity and hypertension.
Based on the Beijing Child and Adolescent Metabolic Syndrome (BCAMS) study, we confirmed that FTO rs9939609, MC4R rs17782313, BDNF rs6265, GNPDA2 rs10938397 were associated with obesity risk and obesity-related indices (for example, BMI, waist circumference, waist-to-height ratio and fat mass percentage), whereas no significant association was found for seven other loci (FAIM2, NPC1, PCSK1, KCTD15, BAT2, SEC16B, SH2B1). [15] [16] [17] In this study, based on the same population of Chinese children, we aimed to examine the associations of 11 obesity-associated SNPs (individually and in combination) with BP/hypertension and to determine the effect of BMI on the associations.
SUBJECTS AND METHODS Subjects
Subjects were recruited from the cross-sectional population-based BCAMS study. 18 The survey included completion of a questionnaire, a medical examination, anthropometric measurements and finger capillary blood tests from a representative sample of Beijing school-aged children (N ¼ 19 593, age range 6-18 years, 50% boys) in 2004. Anthropometric measurements included weight and height; medical examination included systolic BP (SBP) and diastolic BP (DBP). Based on the Chinese children age-and sex-specific BP criteria (Supplementary Table S1) , 19 the prevalence of hypertension was 8.5%, equal to 1662 hypertensive cases among 19 593 BCAMS children aged 6-18 years. Although informed consent was requested from all the children and/or their parents/ guardians, only 619 out of 1662 hypertensive children participated in a 12-h overnight fasting venous blood testing. The distribution of age, sex, BP values and severity of hypertension were comparable between 619 and the rest of 1043 hypertensive children, who refused to participate in the study (all P40.05). None of the 619 hypertensive children were on antihypertensive drugs. In addition, 2458 normotensive children from the BCAMS Study provided informed consent for participation in the study and agreed to undergo testing on their fasting blood. All participating children and their parents gave written informed consent under protocols provided by the Capital Institute of Paediatrics that clearly stated that blood samples would be used for scientific research purposes, including genetic studies. The BCAMS study was approved by the ethics committee and institutional review board of the Capital Institute of Paediatrics.
Measurement of BP
Hypertension is defined as elevated BP at two separate occasions (in other words, if a child had inconsistent BP results at two separate occasions, he/she was not considered as hypertensive individual; only children with hypertension at two separate occasions were diagnosed to be hypertensive). Resting BP was measured in accordance with standard procedures and recommendations. 20 At each separate occasion, after sitting quietly for 5 min, BP was measured by auscultation using a standard clinical sphygmomanometer. Measurements were taken on the right arm in sitting position with the elbow at the level of the right atrium, using an appropriately sized cuff. SBP was determined by the onset of the first Korotkoff sound (K1) and DBP was determined by the fourth Korotkoff sound (K4) (it should be noted that as the fifth Korotkoff sound (K5) is recommended by the National Heart, Lung and Blood Institute, 20 our measurement of DBP using K4 should be interpreted with caution, although childhood K4 seems be superior to K5 in predicting hypertension in adulthood 21 ). Three consecutive measurements were performed, and the mean of the three readings was used for analysis.
Selection of SNPs and genotyping
We chose the 11 SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397, BDNF rs6265, FAIM2 rs7138803, NPC1 rs1805081, SEC16B rs10913469, SH2B1 rs4788102, PCSK1rs6235, KCTD15 rs29941, BAT2 rs2844479) that have been shown to be significantly associated with the risk of obesity by the GWAS. [6] [7] [8] [9] [10] [11] We had sufficient power (40.75) to detect the effect of these SNPs on hypertension (the power calculation was performed using Quanto software (USC, Los Angeles, CA, USA) (http://hydra.usc.edu/gxe/).
Genomic DNA was isolated from peripheral blood white cells using the salt fractionation method. SNPs were genotyped by TaqMan Allelic Discrimination Assays with the GeneAmp 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Genotyping call rates for all SNPs were 499%. In order to validate the accuracy of genotyping, we repeated 70 samples randomly for each SNP and observed 100% concordance between the results of the two tests.
Statistical analysis
Continuous variables were expressed as means ± s.d., and differences between groups were assessed with the Student's t-test. Categorical variables were represented as percentages and were tested by the w 2 -test.
Hardy-Weinberg equilibrium was assessed using the w 2 test. The risk alleles of 11 SNPs were determined based on the recent GWAS. The weighted SBP or DBP genetic risk score (GRS) was a weighted sum across three significant SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397) combining b coefficients and doses of risk alleles, rounded to 1 mm Hg for SBP and 0.5 mm Hg for DBP. 22 The weighted hypertension risk score was assessed as the sum of doses of the risk alleles weighted by the logarithm of the odds ratio (OR) at the polymorphisms. 22 The associations of 11 SNPs and GRS with SBP, DBP and risk of hypertension were estimated using multivariate linear regression model (continuous variable) and multivariate logistic regression model (categorical variable), respectively, assuming an additive model and with adjustment for sex, age, BMI and hypertension status (when appropriate). The Bonferroni correction was used to control for multiple testing (0.05/11 ¼ 0.0045). Statistical analyses were performed with SPSS, version 13.0 (SPSS, Inc., Chicago, IL, USA).
RESULTS
Characteristics of the study population A total of 619 hypertensive and 2458 control children with normal BP were included in the present study. The frequency of sex and mean BP and BMI were statistically significant between the hypertension and control groups (all Po0.001); the mean age of the two groups were not different (P ¼ 0.774; Table 1 ). The genotypes of 11 SNPs were in Hardy-Weinberg equilibrium (all P40.05, data not shown).
Associations of 11 SNPs with SBP, DBP and hypertension In the models adjusted for age, sex and hypertension status, only Table 2 ). In addition, three SNPs were significantly associated with hypertension risk after adjustment for age and sex (FTO rs9939609: OR ¼ 1.35, 95% CI 1.12-1.62, P ¼ 0.001; MC4R rs17782313: OR ¼ 1.22, 95% CI 1.06-1.42, P ¼ 0.007; GNPDA2 rs10938397: OR ¼ 1.17, 95% CI 1.02-1.34, P ¼ 0.021; Table 3 ). After additional adjustment for BMI, none remained statistically significant (Tables 2 and 3 ). After correction for multiple testing, only FTO rs9939609 was statistically associated with hypertension risk in the age-and sex-adjusted model.
The GRS, based on the cumulative effect of the three significant SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397), showed a positive association with SBP (b ¼ 0.55, 95% CI 0.24-0.86, P ¼ 5.17 Â 10 À 4 ), DBP (b ¼ 0.33, 95% CI 0.07-0.59, P ¼ 0.013) and risk of hypertension (OR ¼ 1.22, 95% CI 1.12-1.33, P ¼ 6.07 Â 10 À 6 ). The statistically significant 
DISCUSSION
In the present study, we examined the associations of 11 recently identified obesity loci with BP/hypertension in the Chinese Abbreviations: BMI, body mass index; CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism.
Obesity loci and hypertension in children B Xi et al children with a relatively large sample size (n ¼ 3077). The results indicated that only FTO rs9939609 was statistically significantly associated with hypertension risk (OR ¼ 1.35, 95% CI 1.12-1.62, P ¼ 0.001). Interestingly, the association seemed to be mediated by adiposity as the positive association was abolished after additional adjustment for BMI. The GRS, based on the three significant SNPs, also showed an increased risk of hypertension. However, similar with FTO rs9939609, the statistical association disappeared after adjustment for BMI. As obesity is the main risk factor for hypertension, targeted weight loss programs in population with high-risk genetic alleles will also be beneficial to reduce the risk of hypertension. Initially, the FTO and MC4R loci were reported to be associated with type 2 diabetes through the effect on BMI in Europeans by two GWASs. 6, 7 Subsequently, many studies have attempted to replicate these associations in different ethnic populations. However, the results have been inconsistent. Interestingly, two recent meta-analyses indicated that the FTO and MC4R loci were associated with type 2 diabetes independently of BMI. 23, 24 In addition, two other GWASs 8, 9 have reported the associations between other identified BMI loci and risk of type 2 diabetes. However, for several other loci, the inclusive findings warrant further investigation. Moreover, FTO rs9939609 SNP was reported to be associated with higher fasting insulin, glucose, triglycerides and lower high-density lipoprotein cholesterol through the effect on BMI. 25 These findings also need further replication. To date, five studies have investigated the association of FTO SNP with hypertension, [26] [27] [28] [29] [30] and only one study has examined the association of MC4R SNP with hypertension, 27 while no study has been performed to assess whether other obesity loci are associated with hypertension. For FTO gene, five studies suggested a significant association, [27] [28] [29] [30] but one study revealed null association. 26 In addition, only two studies 29, 30 considered the effect of adiposity (BMI) on the association and both indicated non-significant association between FTO gene SNP and hypertension after adjustment for BMI. For MC4R locus, only one study have reported its association with hypertension in the Danish adults but found the null association without adjustment for BMI (OR ¼ 1.02, 95% CI 0.99-1.06). 27 To our knowledge, our study represents the first investigation of the associations between obesity susceptibility loci with hypertension in the children population, although one study in European children showed a marginally significant association of SBP with FTO SNP (P ¼ 0.04) and a null association with MC4R SNP (P ¼ 0.99). 31 The mechanisms of how these obesity loci influence BP/hypertension are currently unclear. FTO protein is highly expressed in the hypothalamus and seems to have an important role in the energy homeostasis. 9 Actually, many studies have also indicated that SNPs in the FTO influences energy-dense food intake rather than regulation of energy expenditure. 32 In addition, the hypothalamus is also known to be a powerful regulator of BP, 33 and the FTO-hypertension association might be related to the regulation of sympathetic vasomotor tone. 28 Like FTO protein, 10 other proteins are also highly expressed in hypothalamus. 9 The associations between these loci and BP/hypertension are less clear as the function of these proteins have not been studied extensively. Thus, functional data on FTO, MC4R or GNPDA2 with respect to their involvement in BP regulation are limited, and functional data with respect to molecular genetic aspects are still required to be investigated.
The present study demonstrated that three SNPs located in/ near FTO, MC4R and GNPDA2 genes, as well as the GRS, were significantly associated with BP/hypertension, which seem to be dependent on BMI. The findings from the present study have great public health significances. Individuals with high-risk alleles could be prescribed lifestyle modifications such as weight loss, in order to offset risk of hypertension development. However, larger studies with consideration of the effect of BMI will be required to confirm or refute our findings of 11 SNPs with hypertension. Obesity loci and hypertension in children B Xi et al
